1. A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS. Issue 12 (December 2018) Authors: Fenaux, Pierre; Santini, Valeria; Spiriti, Maria; Giagounidis, Aristoteles; Schlag, Rudolf; Radinoff, Atanas; Gercheva-Kyuchukova, Liana; Anagnostopoulos, Achilles; Oliva, Esther; Symeonidis, Argiris; Berger, Mathilde; Götze, Katharina; Potamianou, Anna; Haralampiev, Hari; Wapenaar, Robert; Milio... Journal: Leukemia Issue: Volume 32:Issue 12(2018) Page Start: 2648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia: results from a prospective, 1-year, non-interventional study (InORS). (September 2014) Authors: Schreiner, Andreas; Svensson, Anders; Wapenaar, Robert; Cherubin, Pierre; Princet, Patricia; Serazetdinova, Larisa; Zink, Mathias Journal: World journal of biological psychiatry Issue: Volume 15:Number 7(2014) Page Start: 534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P271 To what extent are baseline characteristics in biologic-experienced patients with psoriatic arthritis associated with achievement of minimal disease activity at week 24 of guselkumab treatment: a post hoc analysis of the phase IIIb COSMOS clinical trial. (23rd April 2022) Authors: Tillett, William; Ohrndorf, Sarah; Ramírez, Julio; Neuhold, Marlies; Wapenaar, Robert; Theander, Elke; Contre, Christine; Sharaf, Mohamed; Shawi, May; Vis, Marijn Journal: Rheumatology Issue: Volume 61(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗